Guidelines: Difference between revisions

No edit summary
Line 5: Line 5:
==== Prostate ====
==== Prostate ====


* ''' <span style="color:#008000">NEW!</span>''' [[Advanced Prostate Cancer (2020 AUA Guidelines)|Advanced Prostate Cancer (2023)]]
* [[Advanced Prostate Cancer (2020 AUA Guidelines)|Advanced Prostate Cancer (2023)]]
*[[AUA: Early Detection of Prostate Cancer (2023)|Early Detection of Prostate Cancer/Prostate Cancer Screening (2023)]]
*[[AUA: Early Detection of Prostate Cancer (2023)|Early Detection of Prostate Cancer/Prostate Cancer Screening (2023)]]
*[[AUA & ASTRO & SUO: Clinically Localized Prostate Cancer (2022)|Clinically Localized Prostate Cancer (2022)]]
*[[AUA & ASTRO & SUO: Clinically Localized Prostate Cancer (2022)|Clinically Localized Prostate Cancer (2022)]]
Line 35: Line 35:
==== Andrology ====
==== Andrology ====


* [[Testosterone Deficiency (2018)]]
* '''<span style="color:#008000">NEW!</span>''' [[Priapism|Priapism (2021)]]
*[[Testosterone Deficiency (2018)]]
* [[AUA & CUA: Erectile Dysfunction (2021 CUA, 2018 AUA)|Erectile Dysfunction (2018)]]
* [[AUA & CUA: Erectile Dysfunction (2021 CUA, 2018 AUA)|Erectile Dysfunction (2018)]]
* [[Peyronie's Disease (2015)]]
* [[Peyronie's Disease (2015)]]
Line 70: Line 71:
*Interstitial cystitis/bladder pain syndrome (2022)
*Interstitial cystitis/bladder pain syndrome (2022)
*Infertility (2021)
*Infertility (2021)
* Priapism (2021)
* Neurogenic LUTD (2021)
*Neurogenic LUTD (2021)
*Disorders of ejaculation (2020)
*Disorders of ejaculation (2020)
* OAB (2019)
* OAB (2019)